期刊文献+

原发中枢神经系统淋巴瘤17例

Chlinic Analysis of Primary Center Nervous Lymphoma
下载PDF
导出
摘要 目的探讨原发中枢神经系统淋巴瘤的治疗方法和预后。。方法回顾性分析了17例患者。按AnnArbor分期标准,IE期3例,IIE期9例,Ⅲ-Ⅵ期5例。结果全组5年生存率为47.1%,IE、IIE期5年生存率分别为66.7%和40.0%,Ⅲ-Ⅵ期5年生存率为0。结论经综合治疗,中枢神经系统淋巴瘤的预后明显改善。建议对早期中枢神经系统淋巴瘤进行正规、足量、联合化疗。 Objective To explore the prognosis of patients with Primary center nervous lymphoma. Methors In the period of 1995 to 2002, 17 patients with Primary center nervous Iymphoma were treated and the therapentre effects were reviewed. There were three patients in stage Ⅰ, nine in stage Ⅱ, and five patients in stage Ⅲ and Ⅳ. Results The fiveyear survival rates were 47.1%, while the 5 - year survival rates by stage were 66.7%, 40.0% for stage Ⅰ, Ⅱ respectively and 0 for stage Ⅲ and Ⅳ. Conclusion The prognosis of primary Primary Primary center nervous Iymphoma get better affcter multi - modality treatment, and postorchidecto my chemotherapy is necessary for stage Ⅰ and stage Ⅱ patients.
作者 关建民
出处 《菏泽医学专科学校学报》 2009年第2期14-15,共2页 Journal of Heze Medical College
关键词 中枢神经系统 淋巴瘤/诊断 淋巴瘤/治疗 Center nervous Lymphoma Chemotherapy/diagnose Chemotherapy/therapy
  • 相关文献

参考文献8

  • 1Bouman SJ Honmtological manifeation of rheumatoid arthritis scand[J].J Rheumatol 2002,31:251-259.
  • 2马旭东,陈元仲,林为澄,郑瑞玑,吴文乔,游慧萍.EB病毒BNLF-1基因在淋巴瘤和急性白血病的表达及临床意义[J].福建医科大学学报,2001,35(4):328-331. 被引量:4
  • 3Van de kolk 2 E,Grillo-lope2AJ-Baars J W et al.Treameat of relapsed B-cell non-Hodgkin's lymphoma uith a Combination ofchimere ant-CD20 monoclonal antibodies and:G-csf:final report on-safety and efficaey[J].Lewkemia,2003,17(8):1658-1664.
  • 4奥斯伯F 布伦特R 金斯顿RE 等 颜子颖 王海林 编译.精编分子生物学实验指南[M].北京:科学出版社,1998.366-373.
  • 5Sugimachi k lefrere F,Hermine o Betal,Fludarrabine:an effective treatment in palients splentic lymphoma with villous lymphoayles[J].lerkenia.2002,14:573-575.
  • 6Connors Jm,Klimo P,Voss N,Testictdar lymphoma:improved outocome with early brief chemotherapy[J].J clin oncot,1998,6(5):776-781.
  • 7Pectasides D,Economopoaulos T,kouvatseas G,Etal.Anthracycline -based chemotherapy of primaryNon-Hodgkin's lymphoma:the Hellenic cooperative oneology group oxperience[J].Oncology,2000,58(4):286-292.
  • 8Doll Takebe N,AdnikariD,etal,Gene therapy for endometrial cercinome with the herpes simplex thymidine kinase gene(J].Gynecol oncol,2000,76(3):305-310.

二级参考文献6

  • 1Kirstsian S,Suat -Cheng P,Brake SA,et al.Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus ( EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas[].Blood.1994
  • 2Ohshima-K,Kikuchi M Shibata T,et al.Clonal analysis of Hodgkins disease shows absence of TCR Ig gene rearrangement compared with T cell -rich B-cell lymphoma and incipient adult T-cell leukemia lymphoma[].Leukemia and Lymphoma.1994
  • 3Baichwal VR,Hammerschmidt W,Sugden B.Characterization of the BNLF-1 oncogene of Epstein-Barr virus[].Current Topics in Microbiology and Immunology.1989
  • 4Hammerschmidt W,Sugden B,Baichwal VR.The transforming domain alone of the latent membrane protein of EpsteinBarr virus is toxic to cells when expressed at high levels[].Journal of Virology.1989
  • 5David J,Alice E,Edith B,et al.Epstein-Barr virus burden in Hodgkins disease is related to latent membrane protein gene expression but not to active virus replication[].Blood.1992
  • 6Hammarskjold M L,Simurdra M C.Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NFkappa B activity[].Journal of Virology.1992

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部